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• There are over 17,000 care homes in England 
(www.CQC.org.uk) offering a significantly 
larger pool of ‘services’ than a ‘standard’ NHS-
based trial. 
• To ensure generalisability of results, the care 
homes were selected for invitation to 
participate via a stratified random sample of a 
known sampling frame. 
• This was done by: 
1) Defining ‘catchment areas’ around each of 
the 3 participating ‘hubs’ (W Yorkshire, 
London, Oxfordshire) 
2) Screening for initial eligibility using publicly 
accessible data (CQC) 
3) Randomly ordered listings of all eligible 
care homes within each area were 
produced 
4) Batches of care homes were sent trial 
information and followed up by researchers 
(who then screened for full eligibility). 
• Note: Whilst this is a time consuming and 
relatively onerous process, it ensured that 
there was no selection bias over the homes 
chosen to participate and has allowed the trial 
team to identify and consent eligible homes 
from this large pool of possible homes 
relatively quickly. 
 
 
 
 
• The DCM™ EPIC Trial aims to evaluate the 
clinical-, and cost-effectiveness of Dementia 
Care Mapping™ in addition to Usual Care vs. 
Usual Care alone for people with dementia 
living in care homes in England. 
• The trial aims to recruit 50 care homes (750 
residents) over a 15 month period (to end of 
2015).  
• Conducting trials in care homes, however, 
comes with a number of challenges which 
are explored below. 
 
• Trial participation involves more than just the care home 
themselves, so as well as ‘consenting’ eligible care homes, 
the trial is also recruiting: 
1) Care home residents with dementia 
2) A staff proxy informant for each resident 
3) A relative / friend proxy informant for each resident (if 
available and willing) 
4) Two mappers at each home, to be trained and deliver the 
DCM™ intervention, if randomised to the DCM™ arm 
5) All care home staff are then given a questionnaire 
booklet to complete. 
• Eligibility must be confirmed for all ‘roles’, and fully informed 
consent must be obtained. This involves complex, lengthy 
discussions with all parties and provision of tailored 
information sheets specific to each ‘role’. 
• Whilst identifying staff proxy informants is relatively 
straightforward, relative / friend proxy informants are, in 
some cases, a little more difficult. Relative / friends are not 
always present in the home during the researcher visit, and 
researchers are therefore reliant on care homes posting the 
trial materials out directly to the relative / friends, as the 
researcher has no consent to access their details at this 
point. This has the potential for delays. 
• Appropriate mapper selection is vital to ensure the 
intervention can be delivered in the homes. Thus selected 
mappers have to posses certain skills and capabilities to 
enable them to take on this role. Detailed discussions take 
place between consented mappers and trial experts to 
ensure suitability, which can again add to the time needed 
for recruitment. 
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All 50 care homes have been identified and have 
agreed to take part. The trial is recruiting slightly 
behind target, but is still on course to randomise 
all 50 homes in line with the initial target. 
Contacts: Prof Claire Surr (c.a.surr@leedsbeckett.ac.uk; Kayleigh Burton k.v.burton@leeds.ac.uk  
• As with all trials, DCM™ EPIC has only a finite 
number of researchers and resources. Thus the 
trial team needed to ensure there was enough 
manpower to undertake screening, consent, 
recruitment, baseline and follow-up data 
collection (at 6- and 16-months post-
randomisation). 
• A staggered recruitment schedule was devised 
and ‘slots’ were allocated for each hub - both 1) 
as already stated, to ensure there is enough 
manpower to cover all care home visits, and 2) 
to ensure there were enough places available 
on DCM™ courses to accommodate recruited 
mappers (homes are allocated to the DCM™ 
plus usual care arm of the trial at a ratio of 3:2) 
• A schedule, as per the below, was devised for 
each of the hubs (and overall) to manage this 
workload. Each home has a ‘planned’ and then 
actual line, which gives at-a-glance 
visualisation of slippages occurring as a result 
of delays at various points in the process.  
• This has been an invaluable way of scheduling 
in workload across the hubs and managing 
delays in real time - switching care home slots, 
as required, and ensuring all homes are 
randomised in time ahead of their allocated 
DCM™ course. 
• Carrying out research in the care home 
environment can have many complex 
challenges. 
• Each stage, from initial selection of services 
invited to participate, through to recruitment of 
participants, requires careful thought and 
planning at the outset to ensure the trial can 
be successfully implemented within the time 
constraints of the grant funding. 
• Inclusion of participants with diminished 
capacity brings with it additional challenges, 
but again careful consideration and 
anticipation of potential problems early on in 
the life of the trial mean that any issues 
encountered are dealt with swiftly. 
• Care homes offer a diverse environment in 
which to carry out research, and growing 
interest and enthusiasm within care home 
teams means challenges encountered needn’t 
be a barrier to successful implementation of 
trials. 
• Care home research is essential to fully 
understand care needs. The EPIC trial 
illustrates that it can be done. 
• Given the target population for the trial (care 
home residents with dementia), a significant 
proportion of potential participants are deemed 
to lack capacity at screening, in accordance 
with the Mental Capacity Act 2005.  
• For those eligible residents who are assessed 
as lacking capacity, a ‘Personal Consultee’ is 
appointed who can be consulted about what 
the residents’ wishes would be if they had 
capacity. Where there is no one able or willing 
to take on this role, another independent 
person (a member of the care home staff not 
involved in the research in any way) who 
knows the resident well is appointed as a 
‘Nominated Consultee’. 
• Whilst this process adds substantial time to the 
consenting process, it ensures all relevant 
parties have been appropriately consulted 
prior to obtaining consent. 
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